BALYASNY ASSET MANAGEMENT L.P. - SYROS PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 70 filers reported holding SYROS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
EDGAR links
External links
Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of SYROS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$14,000
-89.6%
14,830
+44.0%
0.00%
-100.0%
Q1 2018$134,000
-53.0%
10,300
-64.8%
0.00%0.0%
Q4 2017$285,000–29,300–0.00%–
 Download
Other shareholders
SYROS PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 881,450$5,677,0001.32%
IFP Advisors, Inc 50$1,0000.00%
Ten Capital Wealth Advisors, LLC 219$1,0000.00%
View complete list of SYROS PHARMACEUTICALS INC shareholders